These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8391927)

  • 21. [Krukenberg tumor: a clinico-pathological study of 5 cases].
    Ben Brahim E; Chatti S; Ayachi M; Zidi Y; Belhaj Salah M; Ben Othman M; Zouaoui T; Sassi S
    Tunis Med; 2007 Sep; 85(9):806-10. PubMed ID: 18254316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Case of Krukenberg's tumor originating in the stomach with a marked increase in the ascitic carcinoembryonic antigen (CEA) level in comparison with that of the blood].
    Kohno H; Morimoto S; Onishi T; Tahara Y; Kumahara Y
    Nihon Naika Gakkai Zasshi; 1983 Apr; 72(4):462-7. PubMed ID: 6310009
    [No Abstract]   [Full Text] [Related]  

  • 23. Functional heterogeneity of CD44 molecules in ovarian cancer cell lines.
    Cannistra SA; DeFranzo B; Niloff J; Ottensmeir C
    Clin Cancer Res; 1995 Mar; 1(3):333-42. PubMed ID: 9815989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B7-H4 overexpression in ovarian tumors.
    Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
    Esheba GE; Pate LL; Longacre TA
    Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations.
    Kiyokawa T; Young RH; Scully RE
    Am J Surg Pathol; 2006 Mar; 30(3):277-99. PubMed ID: 16538048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The proliferative activity of ovarian tumors of low malignant potential differs from that of ovarian carcinoma.
    Nakayama K; Takebayashi Y; Hata K; Fujiwaki R; Iida K; Fukumoto M; Miyazaki K
    Anticancer Res; 2003; 23(6C):4657-62. PubMed ID: 14981910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
    Pisano C; Greggi S; Tambaro R; Losito S; Iodice F; Di Maio M; Ferrari E; Falanga M; Formato R; Iaffaioli VR; Pignata S
    Anticancer Res; 2005; 25(5):3501-5. PubMed ID: 16101169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production and characterization of monoclonal antibodies against a human ovarian teratocarcinoma cell line.
    Lemieux P; Pagé M
    Anticancer Res; 1994; 14(6B):2709-15. PubMed ID: 7872706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status.
    Fishman A; Dekel E; Chetrit A; Lerner-Geva L; Bar-Am A; Beck D; Beller U; Ben-Baruch G; Piura B; Friedman E; Struewing JP; Modan B
    Gynecol Oncol; 2000 Oct; 79(1):74-8. PubMed ID: 11006035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Distribution and ultrastructural localization of carcino-embryonic antigen (CEA) in signet-ring cells of gastric cancer].
    Yang GL
    Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):111-3. PubMed ID: 2553362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic significance of elongation factor eEF1A2 in ovarian cancer.
    Pinke DE; Kalloger SE; Francetic T; Huntsman DG; Lee JM
    Gynecol Oncol; 2008 Mar; 108(3):561-8. PubMed ID: 18164751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique.
    Ren J; Chen Z; Juan SJ; Yong XY; Pan BR; Fan DM
    Cancer; 2000 Jan; 88(2):280-5. PubMed ID: 10640958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Macrophage-colony stimulating factor and ovarian cancer].
    Menditto A; Piscittelli V; Cassese F; Balbi GC; Balbi C; Cardone A
    Minerva Ginecol; 1999; 51(7-8):261-4. PubMed ID: 10536419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An antiserum to ovarian mucinous cyst fluid with colon cancer specificity.
    McNeil C; Ladle JN; Helmick WM; Trentelman E; Wentz MW
    Cancer Res; 1969 Aug; 29(8):1535-40. PubMed ID: 4308954
    [No Abstract]   [Full Text] [Related]  

  • 37. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum.
    Kang H; O'Connell JB; Maggard MA; Sack J; Ko CY
    Dis Colon Rectum; 2005 Jun; 48(6):1161-8. PubMed ID: 15868237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.
    Garin-Chesa P; Campbell I; Saigo PE; Lewis JL; Old LJ; Rettig WJ
    Am J Pathol; 1993 Feb; 142(2):557-67. PubMed ID: 8434649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of signet-ring cells in patients with colorectal cancer.
    Pande R; Sunga A; Levea C; Wilding GE; Bshara W; Reid M; Fakih MG
    Dis Colon Rectum; 2008 Jan; 51(1):50-5. PubMed ID: 18030531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.